The Biden Administration has announced it will impose new minimum staffing rules for nursing homes. But the regulations appear to give facilities time to meet the requirements. Separately, the Administration also is requiring that home care agencies allocate at least 80 percent of their Medicaid payments to staff compensation. States would have flexibility to adjust the rules for small and [...]
The federal government wants to know more, and wants consumers to know more, about who owns nursing homes. It is about time. And it may help identify some of the worst actors who pollute the nursing home industry. However, without easier access to this new information, I’m not sure how helpful it will be for prospective residents and their families. [...]
The drug industry and its supporters are blasting the Centers for Medicare and Medicaid Services (CMS) for proposing to limit Medicare payments for the new anti-Alzheimer’s drug lecanemab to patients who participate in a trial or a special registry aimed at tracking their experience with the drug. CMS says the record-keeping will help provide important, real-world information about the benefits [...]
The powerful Alzheimer’s Disease lobby is fighting a multi-billion-dollar battle on two fronts. It is quietly trying to limit restrictions the Food and Drug Administration puts on the use of new drugs aimed at slowing the progression of the brain disease. And it is publicly pressing Medicare to pay for the widespread use of the monoclonal antibodies FDA already has [...]
Nursing homes have been pressing for more money from the state and federal governments, by far their biggest payers. Now they are close to getting it, but the extra payments may come with costly new obligations, especially related to staffing. The federal government is about to increase Medicare payments for skilled nursing care and, at the same time, states are [...]
The Biden Administration has proposed a wide range of changes in the regulation of nursing homes. They include efforts to require minimum staffing levels; limit shared rooms; enhance inspections, penalties, and transparency; and crack down on owners with a history of poor quality. The plan also would expand a technical assistance program to help operators improve their quality of care. [...]
Over just the past few decades, the life expectancy of people with Down Syndrome (DS) has increased from less than 30 years to nearly 60. But for many, that remarkable advancement comes at a high price. As they live longer, up to ninety percent of people with DS will have Alzheimer’s Disease. It is, in fact, the leading cause of death [...]
With nursing homes and other long-term care facilities desperately short of nurses and aides, it is more important than ever for consumers to know about staffing levels, quality, and turnover. But it has been difficult to get some key information. Now, the government has taken a modest step to help. In January, the Centers for Medicare and Medicaid Services (CMS) [...]
In a key decision, the Centers for Medicare and Medicaid Services (CMS) said today that Medicare will not pay for the controversial Alzheimer’s drug Adulhelm until it sees positive results from a government-approved trial. In bureaucratic language: “Monoclonal antibodies directed against amyloid for the treatment of [Alzheimer’s Disease] provided outside of the CMS approved randomized controlled trials and trials supported [...]
Last month, The Food and Drug Administration (FDA) approved a controversial new drug to treat people with Alzheimer’s disease. But even though the FDA allowed the drug to be sold, Medicare is not required to pay for it. And yesterday, the Centers for Medicare & Medicaid Services (CMS) began a process to determine whether Medicare will establish a national coverage [...]